Novel Drug, First Tx for Rare Uveal Melanoma
A novel drug, the first in its class, is also the first treatment approved for use in uveal melanoma, a rare cancer of the eye, after it was shown to improve overall survival.
Source: medscape.com
Page 19 - Project Orbis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Project Orbis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Project Orbis Today - Breaking & Trending Today
FDA Approves Immunocore's T-Cell Receptor Therapy Kimmtrak for Uveal Melanoma Patients
The drug is the first TCR therapy approved in the US for HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
Source: precisiononcologynews.com
Patients to receive new cancer drugs faster under Brexit rules shake-up
Seven medicines already approved as changes cut as much as a month off approval times
Source: telegraph.co.uk
Enhertu Granted Priority Review in the US for Patients With HER2-Positive Metastatic Breast Cancer Treated With a Prior Anti-HER2-Based Regimen
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Enhertu granted Priority Review for breast cancer
Investegate announcements from AstraZeneca PLC, Enhertu granted Priority Review for breast cancer
Source: investegate.co.uk